NYXH Stock Catalyst: Nyxoah SA Expects Second Tranche of $110M EIB Loan

Jun 9, 2026 · 5:45pm ET

Funds to support U.S. commercialization of Genio

Max move

+34.0%

High of day $1.78

Sparker timei

5:45pm ET

NYXH · Jun 9, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Nyxoah SA, a medical device company focused on the treatment of obstructive sleep apnea, announced it expects to receive the second tranche of a $110 million loan from the European Investment Bank. The anticipated $15 million will be used to pursue the commercialization of its Genio system in U.S. markets.

The total loan amount is $110 million, with the second tranche expected to be $15 million. The funds will specifically target the expansion and market introduction of Genio in the United States.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time NYXH sparks.

Download Sniper App →

Catch the next NYXH-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →